6-Fluoro-2-chloronaphthalin | 59079-71-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 6-Fluoro-2-chloronaphthalin
• 英文别名: 2-Fluor-6-chlornaphthalin；2-Chloro-6-fluoronaphthalene
• CAS: 59079-71-9
• 化学式: C₁₀H₆ClF
• 分子量: 180.609
• InChiKey: QWAOODAKUAYDQK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  6-氟-2-萘胺 生成 6-Fluoro-2-chloronaphthalin
  参考文献：
  名称：

  Substituent effects in the naphthalene ring system by fluorine-19 NMR

  摘要：

  DOI：

  10.1021/ja00423a012

文献信息

• [EN] ARYLCARBOXAMIDES AND USES THEREOF<br/>[FR] ARYLCARBOXAMIDES ET LEURS UTILISATIONS
  申请人：INCEPTION 1 INC

  公开号：WO2017192304A1

  公开（公告）日：2017-11-09

  The present disclosure is directed to compounds of formula (I): or a pharmaceutically acceptable salt, solvate or solvate of the salt thereof. Compounds of formula (I) are inhibitors of NOX4 and are useful in the treatment of fibrotic diseases such as scleroderma; lung disease, such as pulmonary fibrosis including idiopathic pulmonary fibrosis (IPF); heart disease, such as heart failure due to ischaemic heart disease, valvular heart disease and hypertensive heart disease, diabetic cardiomyopathy and hypertension; liver disease, such as cirrhosis of the liver; and kidney disease, such as progressive kidney disease glomerulonephritis and diabetic nephropathy; and eye disease such as diabetic retinopathy; skin or subcutaneous scarring, such as keloids, adhesions, hypertrophic scarring or cosmetic scarring; or as an adjuvant or anti-fibrotic in pancreatic cancer to increase chemotherapeutic drug penetration by reducing the density of the connective tissue stroma.

  本公开涉及的化合物具有以下结构式（I）：或其药学上可接受的盐、溶剂或该盐的溶剂。结构式（I）的化合物是NOX4的抑制剂，可用于治疗纤维化疾病，如硬皮病；肺部疾病，如肺纤维化，包括特发性肺纤维化（IPF）；心脏疾病，如缺血性心脏病、瓣膜性心脏病和高血压性心脏病、糖尿病性心肌病和高血压；肝脏疾病，如肝硬化；肾脏疾病，如进行性肾脏疾病肾小球肾炎和糖尿病肾病；眼部疾病，如糖尿病视网膜病变；皮肤或皮下疤痕，如瘢痕、粘连、肥厚性瘢痕或美容瘢痕；或作为胰腺癌的辅助治疗或抗纤维化剂，通过减少结缔组织基质密度来增加化疗药物的渗透性。
• NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR
  申请人：OSAKA UNIVERSITY

  公开号：US20190337966A1

  公开（公告）日：2019-11-07

  In order to provide a naphthobischalcogenadiazole derivative that can be used as an intermediate for producing a naphthobischalcogenadiazole compound into which a fluorine atom has been introduced, the naphthobischalcogenadiazole derivative in accordance with an aspect of the present invention is represented by a formula (I): where each of A 1 and A 2 is independently an oxygen atom, a sulfur atom, a selenium atom, or a tellurium atom; and each of X 1 and X 2 is independently a hydrogen atom, a halogen atom, a boronic acid group, a boronic acid ester group, a boronic acid diaminonaphthalene amide group, an N-methyliminodiacetic acid boronate group, a trifluoroborate salt group, or a triolborate salt group.

  为了提供一种可用作生产引入氟原子的萘基双硫/硒/碲-二唑化合物的中间体的萘基双硫/硒/碲-二唑衍生物，本发明的一个方面提供的萘基双硫/硒/碲-二唑衍生物由式(I)表示：其中，A1和A2分别独立地为氧原子、硫原子、硒原子或碲原子；X1和X2分别独立地为氢原子、卤素原子、硼酸基、硼酸酯基、硼酸二氨基萘酰胺基、N-甲基亚乙二酸硼酸酯基、三氟硼酸盐基或三羟基硼酸盐基。
• Naphthobischalcogenadiazole derivative and production method therefor
  申请人：OSAKA UNIVERSITY

  公开号：US10793584B2

  公开（公告）日：2020-10-06

  In order to provide a naphthobischalcogenadiazole derivative that can be used as an intermediate for producing a naphthobischalcogenadiazole compound into which a fluorine atom has been introduced, the naphthobischalcogenadiazole derivative in accordance with an aspect of the present invention is represented by a formula (I): where each of A1 and A2 is independently an oxygen atom, a sulfur atom, a selenium atom, or a tellurium atom; and each of X1 and X2 is independently a hydrogen atom, a halogen atom, a boronic acid group, a boronic acid ester group, a boronic acid diaminonaphthalene amide group, an N-methyliminodiacetic acid boronate group, a trifluoroborate salt group, or a triolborate salt group.

  为了提供一种萘二异噻二唑衍生物，该衍生物可用作生产引入了氟原子的萘二 异噻二唑化合物的中间体，根据本发明的一个方面，萘二异噻二唑衍生物由式 (I) 表示： 其中，A1 和 A2 各自独立地为氧原子、硫原子、硒原子或碲原子；X1 和 X2 各自独立地为氢原子、卤素原子、硼酸基团、硼酸酯基团、硼酸二氨基萘酰胺基团、N-甲基二乙酸硼酸盐基团、三氟硼酸盐基团或三硼酸盐基团。
• Substituent effects in the naphthalene ring system by fluorine-19 NMR
  作者：W. Adcock、J. Alste、S. Q. A. Rizvi、M. Aurangzeb

  DOI：10.1021/ja00423a012

  日期：1976.3